vTv Therapeutics Inc. (VTVT) Earnings History
Annual and quarterly earnings data from 2013 to 2025
Loading earnings history...
VTVT EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
VTVT Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | 100.0% | -2377.6% | -1815.3% |
| 2023 | - | - | - |
| 2022 | 100.0% | -1116.9% | -949.7% |
| 2021 | 100.0% | -540.9% | -324.3% |
Download Data
Export VTVT earnings history in CSV or JSON format
Free sign-in required to download data
vTv Therapeutics Inc. (VTVT) Earnings Overview
As of May 8, 2026, vTv Therapeutics Inc. (VTVT) reported trailing twelve-month net income of -$27M, reflecting +0.0% year-over-year growth. The company earned $-3.20 per diluted share over the past four quarters.
Looking at the long-term picture, VTVT's historical earnings data spans multiple years. The company achieved its highest annual net income of -$8M in fiscal 2018.
vTv Therapeutics Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including AVXL (-$40M net income), SAVA (-$106M net income), PRTA (-$151M net income, -2520.6% margin), VTVT has comparable earnings metrics. Compare VTVT vs AVXL →
VTVT Earnings vs Peers
Earnings metrics vs comparable public companies
VTVT Historical Earnings Data (2013–2025)
13 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$27M | -46.1% | -$33M | $-3.20 | - | - |
| 2024 | -$18M | +8.8% | -$24M | $-3.20 | -1815.3% | -2377.6% |
| 2023 | -$20M | -5.7% | -$26M | $-9.71 | - | - |
| 2022 | -$19M | -47.6% | -$23M | $-9.98 | -949.7% | -1116.9% |
| 2021 | -$13M | -52.8% | -$22M | $-8.29 | -324.3% | -540.9% |
| 2020 | -$8M | +61.3% | -$12M | $-7.21 | -132.5% | -184.8% |
| 2019 | -$22M | -177.3% | -$21M | $-28.97 | -793.7% | -755.9% |
| 2018 | -$8M | +51.0% | -$20M | $-25.42 | -63.6% | -159.4% |
| 2017 | -$16M | +1.3% | -$51M | $-66.62 | -5547.8% | -17416.5% |
| 2016 | -$16M | +40.5% | -$55M | $-68.52 | -2579.2% | -8678.2% |
See VTVT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs VTVT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare VTVT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonVTVT — Frequently Asked Questions
Quick answers to the most common questions about buying VTVT stock.
Is VTVT growing earnings?
VTVT TTM EPS: $-3.20. Net income: $-27M. Earnings growth: +0.0%.
What are VTVT's profit margins?
vTv Therapeutics Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are VTVT's earnings?
VTVT earnings data spans 2013-2025. The current earnings trend is +0.0% YoY. Historical data enables comparison across business cycles.